| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18812400P | 2000-03-09 | 2000-03-09 | |
| US60/188,124 | 2000-03-09 | ||
| PCT/US2001/007546WO2001065934A2 (en) | 2000-03-09 | 2001-03-09 | Applications of immune system tolerance to treatment of various diseases |
| Publication Number | Publication Date |
|---|---|
| AU2001245550A1true AU2001245550A1 (en) | 2001-09-17 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001245550AAbandonedAU2001245550A1 (en) | 2000-03-09 | 2001-03-09 | Applications of immune system tolerance to treatment of various diseases |
| Country | Link |
|---|---|
| US (1) | US20010053362A1 (en) |
| AU (1) | AU2001245550A1 (en) |
| WO (1) | WO2001065934A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8460367B2 (en) | 2000-03-15 | 2013-06-11 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
| US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| ATE362382T1 (en)* | 2000-03-15 | 2007-06-15 | Orbusneich Medical Inc | COATING WHICH STIMULATES ADHESION OF ENDOTHELIAL CELLS |
| CA2486621A1 (en)* | 2002-05-22 | 2003-12-04 | The Cleveland Clinic Foundation | Induction and maintenance of tolerance to composite tissue allografts |
| WO2004009767A2 (en)* | 2002-07-23 | 2004-01-29 | Boston Scientific Limited | Cell therapy for regeneration |
| EP1545627A4 (en)* | 2002-10-01 | 2006-12-27 | Univ Duke | TARGETED TUMOR THERAPY USING RECOMBINANT ADENOVIRUS VECTORS WITH SELECTIVE REPLICATION IN THE HYPOXIC REGIONS OF TUMORS |
| US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
| US11191789B2 (en) | 2003-06-27 | 2021-12-07 | DePuy Synthes Products, Inc. | Cartilage and bone repair and regeneration using postpartum-derived cells |
| EP1740219B1 (en) | 2004-04-30 | 2015-03-04 | OrbusNeich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods of using same |
| AU2006320162B2 (en)* | 2005-12-02 | 2013-07-25 | The Johns Hopkins University | Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| EP1971681B1 (en) | 2005-12-16 | 2017-08-23 | DePuy Synthes Products, Inc. | Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
| WO2008034071A2 (en) | 2006-09-15 | 2008-03-20 | The Johns Hopkins University | Method of identifying patients suitable for high-dose cyclophosphamide treatment |
| WO2008034076A2 (en) | 2006-09-15 | 2008-03-20 | The Johns Hopkins University | Cyclophosphamide in combination with immune therapeutics |
| WO2008034074A2 (en) | 2006-09-15 | 2008-03-20 | The Johns Hopkins University | Cyclosphosphamide in combination with anti-idiotypic vaccines |
| US20080294107A1 (en)* | 2007-05-22 | 2008-11-27 | Convergent Medical Solutions, Inc. | Multiple robotic injections of prenatal medications based on scanned image |
| WO2009045464A1 (en)* | 2007-10-01 | 2009-04-09 | The Johns Hopkins University | Methods of treating neurological autoimmune disorders with cyclophosphamide |
| WO2009067690A2 (en)* | 2007-11-21 | 2009-05-28 | Accentia Biopharmaceuticals, Inc. | Methods for safe and effective treatment using oxazaphosphorine drugs |
| US9026372B2 (en)* | 2007-11-21 | 2015-05-05 | Accentia Biopharmaceuticals, Inc. | Methods for providing a system of care for a high-dose oxazaphosphorine drug regimen |
| US20190083457A1 (en)* | 2017-09-15 | 2019-03-21 | The Borad Of Trustees Of The Leland Stanford Junior University | Mitochondrial aldehyde dehydrogenase-2 modulators for protecting, expanding and increasing the potency of hematopoietic stem cells |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU693452B2 (en)* | 1993-05-24 | 1998-07-02 | Ximerex, Inc | Surrogate tolerogenesis for the development of tolerance to xenografts |
| Publication number | Publication date |
|---|---|
| WO2001065934A2 (en) | 2001-09-13 |
| US20010053362A1 (en) | 2001-12-20 |
| WO2001065934A3 (en) | 2002-08-01 |
| Publication | Publication Date | Title |
|---|---|---|
| AU2001245550A1 (en) | Applications of immune system tolerance to treatment of various diseases | |
| AU2002225512A1 (en) | Immune system stimulation | |
| HUP0301815A3 (en) | Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment | |
| IL145470A0 (en) | Compositions for the treatment of immune diseases | |
| AU8038998A (en) | Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters | |
| AU2002364964A1 (en) | Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections | |
| HUP0401392A3 (en) | Use of composition comprising anti-hla-antibody for treatment of diseases involving prolierative immune response | |
| AU4663100A (en) | Treatment of female arousal disorder | |
| AUPQ344799A0 (en) | Treatment of respiratory diseases and infections | |
| AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
| AU2001232053A1 (en) | System for the extracorporeal treatment of blood | |
| AU2002352566A1 (en) | Use of corrinoids in the treatment of skin diseases | |
| AU2002251254A1 (en) | Treatment of neuropathologies associated with expression of tnf-alpha | |
| AU2003260818A1 (en) | Treatment of immune system dysfunction | |
| AU2002365281A1 (en) | Thiochromenones used to combat painful conditions and neurodegenerative diseases | |
| AU1405001A (en) | Treatment of diseases | |
| AU2002210286A1 (en) | Medicine intended for treatment of multiple sclerosis | |
| AU2001255168A1 (en) | Compositions and methods for the treatment of immune related diseases | |
| AU2002214950A1 (en) | Determination of the ability of patients to respond to tumour treatment | |
| AU2001282277A1 (en) | Treatment of mycobacterial infection | |
| AU5812601A (en) | Treatment of il-10 deficiencies | |
| AU2002251271A1 (en) | Stimulation of the immune system | |
| AU2002225550A1 (en) | A method to enhance the immune system and used for the prevention and treatment of infectious diseases | |
| AU3902600A (en) | Compositions and methods for the treatment of immune related diseases | |
| AU6019599A (en) | Use of mcrp to enhance immune responses |